AUB ScholarWorks

Browsing Faculty of Medicine (FM) by Subject "Y-90 IBRITUMOMAB TIUXETAN"

Browsing Faculty of Medicine (FM) by Subject "Y-90 IBRITUMOMAB TIUXETAN"

Sort by: Order: Results:

  • Kharfan-Dabaja M.A.; Nishihori T.; Otrock Z.K.; Haidar N.; Mohty M.; Hamadani M. (NEW YORK360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, 2013)
    Monoclonal antibodies are increasingly being incorporated in conditioning regimens for autologous or allogeneic hematopoietic cell transplantation (HCT). The benefit of adding rituximab to autologous HCT regimens is ...

Search AUB ScholarWorks


Browse

My Account